Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Heterochromatin02:38

Heterochromatin

The extent of chromatin compaction can be studied by staining chromatin using specific DNA binding dyes. Under the microscope, the dense-compacted regions that take up more dye are called heterochromatin. Heterochromatin is further classified into two forms – constitutive heterochromatin and facultative heterochromatin.
Constitutive heterochromatin: It is a highly compact region of chromatin that is mostly concentrated in the centromere and telomere. Unlike euchromatin, the amino acid at 9th...
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence and breakdown of <i>KRAS</i> driver mutations in a large UK non-small cell lung cancer cohort.

Journal of clinical pathology·2025
Same author

Induction of the TEAD Coactivator VGLL1 by Estrogen Receptor-Targeted Therapy Drives Resistance in Breast Cancer.

Cancer research·2024
Same author

Induction of APOBEC3B expression by chemotherapy drugs is mediated by DNA-PK-directed activation of NF-κB.

Oncogene·2020
Same author

A Systematic Review and Mixed Treatment Comparison of Pharmaceutical Interventions for Multiple Sclerosis.

Neurology and therapy·2020
Same author

Overview of Differences and Similarities of Published Mixed Treatment Comparisons on Pharmaceutical Interventions for Multiple Sclerosis.

Neurology and therapy·2020
Same author

Genome-wide alterations of uracil distribution patterns in human DNA upon chemotherapeutic treatments.

eLife·2020

Related Experiment Video

Updated: May 11, 2026

An Integrated Workflow to Study the Promoter-Centric Spatio-Temporal Genome Architecture in Scarce Cell Populations
11:36

An Integrated Workflow to Study the Promoter-Centric Spatio-Temporal Genome Architecture in Scarce Cell Populations

Published on: April 21, 2023

Inactive or moderately active human promoters are enriched for inter-individual epialleles.

Carolina Gemma, Sreeram V Ramagopalan, Thomas A Down

    Genome Biology
    |May 28, 2013
    PubMed
    Summary

    Epiallelic variation in humans is temporally stable and linked to chromatin changes. This epigenetic variation connects normal differences, cancer, and aging processes.

    More Related Videos

    Promoter Capture Hi-C: High-resolution, Genome-wide Profiling of Promoter Interactions
    10:16

    Promoter Capture Hi-C: High-resolution, Genome-wide Profiling of Promoter Interactions

    Published on: June 28, 2018

    Optimized Quantitative Assessment of Enhancer RNA Stability in Mouse Embryonic Stem Cells
    03:34

    Optimized Quantitative Assessment of Enhancer RNA Stability in Mouse Embryonic Stem Cells

    Published on: November 21, 2025

    Related Experiment Videos

    Last Updated: May 11, 2026

    An Integrated Workflow to Study the Promoter-Centric Spatio-Temporal Genome Architecture in Scarce Cell Populations
    11:36

    An Integrated Workflow to Study the Promoter-Centric Spatio-Temporal Genome Architecture in Scarce Cell Populations

    Published on: April 21, 2023

    Promoter Capture Hi-C: High-resolution, Genome-wide Profiling of Promoter Interactions
    10:16

    Promoter Capture Hi-C: High-resolution, Genome-wide Profiling of Promoter Interactions

    Published on: June 28, 2018

    Optimized Quantitative Assessment of Enhancer RNA Stability in Mouse Embryonic Stem Cells
    03:34

    Optimized Quantitative Assessment of Enhancer RNA Stability in Mouse Embryonic Stem Cells

    Published on: November 21, 2025

    Area of Science:

    • Epigenetics
    • Genomics
    • Mammalian biology

    Background:

    • Epigenetic variation exists between individuals in many species.
    • In mammals, epialleles are poorly understood, with a limited focus on DNA methylation.
    • This study provides a genome-scale investigation of mammalian epialleles.

    Purpose of the Study:

    • To investigate the molecular nature of mammalian epiallelic variation.
    • To integrate genomic, methylomic, transcriptomic, and histone data.
    • To define features of human epialleles and their links to biological processes.

    Main Methods:

    • Genome-scale analysis of epialleles.
    • Integration of methylomic, transcriptomic, and histone data.
    • Temporal stability assessment of differentially methylated regions.

    Main Results:

    • Non-genetically determined differentially methylated regions are temporally stable.
    • Epialleles are associated with chromatin state changes, including H2A.Z levels.
    • Promoter epialleles show negligible correlation with gene expression and are linked to transcriptional inactivity.

    Conclusions:

    • Non-genetically determined epialleles exhibit temporal stability and affect chromatin.
    • Epiallelic variation may link normal biological variation, cancer, and aging.
    • Identifies key features of human epiallelic variation.